The global leukemia cancer market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. Increasing investments in the healthcare sector and the rising development of new drugs and therapeutics will drive the market in the forecast period. According to WHO, globally leukemia cancer is considered to be the most common blood cancer. Thus, to treat and cure rising...